Recombinant Human HLA-A*01:01&B2M&CT83 (NTDNNLAVY) Monomer Protein
Beta LifeScience
SKU/CAT #: BLK-00999P-100UG

Human HLA-A*01:01&B2M&CT83 (NTDNNLAVY) Monomer on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human HLA-A*01:01&B2M&CT83 (NTDNNLAVY) Monomer Protein
Beta LifeScience
SKU/CAT #: BLK-00999P-100UG
Collections: Fc receptors, Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human CT83(HLA-A*01:01) Protein is expressed from HEK293 with His tag and Avi Tag at the C-Terminus.It contains Gly25-Thr305(HLA-A*01:01),Ile21-Met119(B2M) and NTDNNLAVY peptide. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | Q5SUL5(HLA-A*01:01)&P61769(B2M)&NTDNNLAVY |
Target Symbol | HLA-A*01:01&B2M&CT83 (NTDNNLAVY) Monomer |
Species | Human |
Expression System | HEK293 |
Tag | C-His-Avi |
Expression Range | Gly25-Thr305(HLA-A*01:01),Ile21-Met119(B2M)and NTDNNLAVY peptide |
Mol. Weight | The protein has a predicted MW of 50.30 kDa. Due to glycosylation, the protein migrates to 55-65 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | Cancer/testis antigens 83 (CT83), also called KK-LC-1 or CXorf61, recognized by cytotoxic T lymphocytes (CTL), has become a promising target for immunotherapy. |